HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 279, Issue 9, 8093-8101, February 27, 2004

This Article Abstract Full Text (PDF) All Versions of this Article: 279/9/8093    most recent M312035200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zylberman, V. Articles by Goldbaum, F. A. Search for Related Content PubMed PubMed Citation Articles by Zylberman, V. Articles by Goldbaum, F. A. Social Bookmarking                      What's this?

High Order Quaternary Arrangement Confers Increased Structural Stability to Brucella sp. Lumazine Synthase^*

Vanesa Zylberman, Patricio O. Craig, Sebastián Klinke, Bradford C. Braden¶, Ana Cauerhff||, and Fernando A. Goldbaum||**

From the Instituto Leloir, Consejo Nacional de Investigaciones Científicas y Técnicas and Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Patricias Argentinas 435 (C1405BWE), Buenos Aires, Argentina and ^¶the Department of Natural Sciences, Bowie State University, Bowie, Maryland 20715

Received for publication, November 3, 2003 , and in revised form, November 26, 2003.

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
The penultimate step in the pathway of riboflavin biosynthesis is catalyzed by the enzyme lumazine synthase (LS). One of the most distinctive characteristics of this enzyme is the structural quaternary divergence found in different species. The protein exists as pentameric and icosahedral forms, built from practically the same structural monomeric unit. The pentameric structure is formed by five 18-kDa monomers, each extensively contacting neighboring monomers. The icosahedrical structure consists of 60 LS monomers arranged as 12 pentamers giving rise to a capsid exhibiting icosahedral 532 symmetry. In all lumazine synthases studied, the topologically equivalent active sites are located at the interfaces between adjacent subunits in the pentameric modules. The Brucella sp. lumazine synthase (BLS) sequence clearly diverges from pentameric and icosahedric enzymes. This unusual divergence prompted us to further investigate its quaternary arrangement. In the present work, we demonstrate by means of solution light scattering and x-ray structural analyses that BLS assembles as a very stable dimer of pentamers, representing a third category of quaternary assembly for lumazine synthases. We also describe by spectroscopic studies the thermodynamic stability of this oligomeric protein and postulate a mechanism for dissociation/unfolding of this macromolecular assembly. The higher molecular order of BLS increases its stability 20 °C compared with pentameric lumazine synthases. The decameric arrangement described in this work highlights the importance of quaternary interactions in the stabilization of proteins.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
Riboflavin, an essential cofactor for all organisms, is biosynthesized in plants, fungi, and microorganisms. The penultimate step in the pathway is catalyzed by the enzyme lumazine synthase (LS).¹ One of the most distinctive characteristics of this enzyme is the structural quaternary divergence found in different species. The protein exists as pentameric and icosahedral forms, built from practically the same structural monomeric unit. The structure of the monomer consists of four repeated -strand/-helix motifs producing a sandwich of four parallel -strands surrounded by four -helices, two on each face of the sheet (1). In all LS studied, the topologically equivalent active sites are located at the interfaces between adjacent subunits in the pentameric modules (2).

Bacilliaceae express a bifunctional enzyme complex with lumazine synthase and riboflavin synthase activity. Three -subunits (riboflavin synthase) enclosed by 60 -subunits (lumazine synthase) form a protein particle of 1 MDa (1, 3). The three-dimensional structure of the lumazine synthase/riboflavin synthase from Bacillus subtilis complexed with a substrate analogue has been determined (4). This structure consists of 60 -subunits (lumazine synthase monomers) arranged as 12 pentamers giving rise to a capsid exhibiting icosahedral 532 symmetry. Two other icosahedric LS have been described by x-ray crystallography. Spinach and thermophilic bacterial Aquifex aelicus LS also exhibit icosahedral 532 symmetry. The three proteins form 1-MDa spherical capsids of 60 LS subunits with icosahedral symmetry. The icosahedral LS structures superimpose very well, highlighting the conservation of the overall folding and quaternary arrangement despite the low sequence homology between them (5).

Four structurally characterized LS assemble as pentamers in their native form and do not further associate to form an icosahedral capsid. These include fungal Magnaporthe grisea, yeast Saccharomyces cerevisiae, and Schizosaccharomyces pombe and bacterial Brucella abortus LS (5). Although the four pentameric enzymes fold in a similar arrangement, the postulated reasons for the lack of icosahedral order differ. Superposition of the pentameric LS shows that the loop connecting the helices 4 and 5 is critical for preventing the formation of capsids. In all icosahedral LS a pentapeptide kink located in this loop is essential for pentamer-pentamer contacts (5, 6). The yeast and fungal pentameric enzymes have insertions of different length in this loop that change its overall orientation and disrupt potential contacts to neighboring subunits (7). We have previously analyzed the divergence in macromolecular assembly between pentameric and icosahedral LS enzymes. In this regard, a high degree of divergence was observed between the sequence from B. abortus LS and the other pentameric structurally characterized members of the family (8). BLS has a 3-residue insertion between helices 4 and 5 that contribute to form a continuous undistorted helix, unable to form the capsid-stabilizing kink (6). Thus, the BLS structure clearly diverges from pentameric and icosahedric enzymes because of the lack of this critical loop. The different orientation of this straight helix is compensated by a longer loop bridging the helix structure with the contiguous sheet. This unusual divergence prompted us to further investigate the quaternary arrangement of BLS. In the present work, we demonstrate by means of solution light scattering and x-ray structural analysis that BLS assembles as a very stable dimer of pentamers, representing a third category of quaternary assembly for LS. We also describe, by spectroscopic studies, the thermodynamic stability of this oligomeric protein and postulate a mechanism for dissociation/unfolding of its macromolecular assembly.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
Expression of the LS Protein
The Brucella sp. LS gene was cloned in pET11a vector (Novagen) as reported previously (9). The plasmid was used to transform BL21(DE3) strain Escherichia coli-competent cells (Stratagene, La Jolla, CA). Ampicillin-resistant colonies were grown until A₆₀₀ = 1.0 in LB medium containing 100 µg/ml ampicillin, at 37 °C with agitation (300 rpm). Five milliliters of this culture was diluted to 500 ml and grown to reach an A₆₀₀ of 1.0. At this point the culture was induced adding 1 mM isopropyl-1-thio--D-galactopyranoside and incubated for 4 h at 37 °C with agitation (300 rpm). The bacteria were centrifuged at 15,000 x g during 20 min at 4 °C.

Protein Purification and Refolding
BLS protein was successfully expressed as inclusion bodies by transformation of strain BL21(DE3) E. coli-competent cells (9). The inclusion bodies were solubilized in 50 mM Tris, 5 mM EDTA, 8 M urea pH 8.0 at room temperature overnight with agitation. The solubilized material was refolded by dialysis during 72 h against phosphate-buffered saline containing 1 mM dithiothreitol. This preparation was purified in a Mono-Q column in a fast-protein liquid chromatography apparatus (Amersham Biosciences, Uppsala, Sweden) using a linear gradient of buffer B (50 mM Tris, 1 M NaCl, pH 8.5). The peak enriched with BLS was further purified on a Superdex-200 column with phosphate-buffered saline buffer, 1 mM DTT. The purity of the BLS preparation was determined on SDS-15% (w/v) polyacrylamide gels. Purified BLS was concentrated (10 mg/ml), frozen in liquid N₂, and stored at -20 °C.

Circular Dichroism
BLS samples were diluted in 50 mM sodium phosphate, pH 7.0, 1 mM DTT, with increasing concentration of denaturants (urea or GdnHCl). All experiments were performed at 25 °C, and samples were incubated at least 2 h before taking CD measurements. Spectra were measured on a spectropolarimeter (JASCO J-810) using either 0.1- or 0.5-cm path length quartz cells. Unfolding was monitored by far-UV CD (260–200 nm) and expressed as the percentage of molar ellipticity at 222 nm as a function of denaturant concentration. The molar ellipticity of the protein incubated without GdnHCl was taken as 100%. For renaturation tests, BLS was first denatured in high concentration of GdnHCl (6 M), and renaturation was induced by overnight dialysis against 50 mM sodium phosphate, pH 7.0, 1 mM DTT. After this treatment, the CD and SLS signals typical of the native protein were recovered.

Intrinsic Fluorescence Measurements
Emission spectra were carried out by excitation of the samples at 295 nm, and data collection from 300 to 450 nm, using 3-nm band passes for both excitation and emission. Experiments were carried out in 50 mM sodium phosphate, pH 7.0, 1 mM DTT in the presence of increasing concentrations of urea or GdnHCl. Samples were incubated for at least 2 h prior to taking fluorescence measurements. All fluorescence emission spectra were measured at 25 °C on a Jasco FP-770 spectrofluorometer.

Thermal Denaturation Monitored by CD
BLS samples were incubated in 50 mM sodium phosphate, 1 mM DTT, pH 7.0 (in the presence or absence of 2 M GdnHCl) or in 50 mM buffer citrate, 1 mM DTT, pH 4.5. Thermal denaturation was conducted by slowly increasing the temperature with a Peltier system (Jasco). The range of temperature scanning was 25–95 °C at a speed of 4 °C/min. Molar ellipticity at 220 nm was measured every 0.5 °C. Fast or slow cooling back to 25 °C (from 95 to 25 °C at a speed of 1 °C/min) did not show a recovery of ellipticity demonstrating the irreversibility of the thermal unfolding. Thus the temperature midpoint of the thermal transition was considered as an apparent T_m.

pH Dependence of LS Unfolding
pH-induced BLS dissociation and unfolding was evaluated by diluting protein samples (5 µM monomers) in 50 mM citrate, 1 mM DTT, pH 6.0–2.5 or in 50 mM sodium phosphate, 1 mM DTT, pH 7.5-7.0. After 1–2 h of incubation at room temperature, CD and SLS signals were determined. ANS fluorescence emission was measured in the same buffer conditions as CD and SLS experiments, aggregating to the samples 50 µM ANS. Values were normalized to ANS fluorescence emission in the same buffer. Excitation and emission were set at 365 and 470 nm, respectively.

Determination of Molecular Weight of BLS by Static Light Scattering
The weight average molecular weight (M_w) of BLS under different conditions was determined on a Precision Detectors PD2010 light-scattering instrument tandemly connected to an high-performance liquid chromatography system and an LKB 2142 differential refractometer. In general, 20–100 µl of LS (0.3–1 mg/ml) was loaded on a Superdex 200 HR-10/30 (24 ml) or a Sephadex G-25 (1 ml) column and eluted with 50 mM phosphate buffer, 1 mM DTT under different pH, urea, GdnHCl, and NaCl conditions. The 90° light scattering and refractive index signals of the eluting material were recorded on a PC computer and analyzed with the Discovery32 software supplied by Precision Detectors. The 90° light scattering detector was calibrated using bovine serum albumin (_w: 66.5 kDa) as a standard. Prior to the injection in a size exclusion chromatography column (SEC), each sample was preincubated for 1–2 h at room temperature in the elution buffer.

Thermodynamic Parameters
Thermodynamics evaluation of GdnHCl-induced unfolding of BLS was fitted to a two-step model: . The first step (N₁₀ 2N₅) represents the dissociation of decameric BLS (N₁₀) in two folded pentamers (N₅), whereas the second step (N₅ 5U) represents the concomitant dissociation and unfolding of the pentameric structure (N₅) in monomeric subunits (U). Because both steps are well resolved from each other, their thermodynamic parameters were independently analyzed using the lineal extrapolation method (Equation 1) assuming a two-state transition model for each step (10),

(Eq. 1)

where G_U is the free energy of unfolding of a protein at a given denaturant concentration, G_H2O is the free energy of unfolding in the absence of denaturant, and m the dependence of the free energy on denaturant concentration ([D]).

Step 1—The first step was monitored by SLS in the range of 1.5–2.2 M GdnHCl. The concentration at equilibrium of the N₁₀ and N₅ species of BLS were calculated using Equations 4 and 5 derived from rearrangement of Equations 2 and 3,

(Eq. 2)

(Eq. 3)

(Eq. 4)

(Eq. 5)

where _w represents the weight average molecular weight of BLS. ccN₁₀, ccN₅, and cc_T represent the decamer, pentamer, and total protein concentration in millgrams/ml, respectively. [N₁₀] and [N₅] represent the molar concentration and _w10 and _w5 the molecular weight of the decameric (174.4 kDa) and pentameric (87.2 kDa) species of BLS, respectively.

The equilibrium constant K_U(1) and the free energy change G_U(1) for Step 1 are defined in Equations 6 and 7.

(Eq. 6)

(Eq. 7)

The G_H2O(1) and m₍₁₎ values (Equation 1) for this transition were obtained from the extrapolation to zero denaturant concentration and from the slope of the linear regression fit of the G_U(1) values calculated as a function of GdnHCl concentration in the range of 1.5 to 2.2 M. The dissociation constant of the decameric arrangement (K_D) was estimated from the G_H2O value of this transition using the equation, K_D = e(-G_H2O/(RT)).

Step 3—The second step was monitored by CD and FT in the range of 2.4 and 3.5 M GdnHCl. The equilibrium constant K_U(2) and the free energy change G_U(2) for this transition are defined in Equations 8 and 9.

(Eq. 8)

(Eq. 9)

The total protein concentration in monomer units (P_T) and the fractional population in the native (F_N) and unfolded (F_U) states were calculated using Equations 10, 11, 12,

(Eq. 10)

(Eq. 11)

(Eq. 12)

where Y is the experimental spectroscopic value, [D] is the GdnHCl concentration, F and U are the intercepts, and m_f and m_u are the slopes of the pre- and post-unfolding baselines, respectively. Combining Equations 1 and 8, 9, 10, 11, 12, we obtain the general equation (Equation 13) as follows.

(Eq. 13)

G_H2O(2) and m₍₂₎ values of Step 2 were obtained fitting the experimental data measured by CD and FT to Equation 13 by a non-linear square fit method. The midpoint of this transition [D]_50% was calculated as in Equation 14.

(Eq. 14)

Crystallization, Data Collection, and Structure Determination
In addition to the previously obtained BLS crystals, which led to the resolution of its three-dimensional structure (6), two further crystal forms of BLS were obtained in this work by means of the hanging drop, vapor diffusion method. The first form was diamond-like crystals obtained using 30% (w/v) polyethylene glycol 400, 0.1 M sodium acetate in 0.1 M MES buffer, pH 6.5, which diffracted to 2.9 Å and belongs to the trigonal space group P3₁21. Furthermore, we obtained plate-like crystals using 12% (w/v) polyethylene glycol 4000, 0.1 M sodium acetate in 0.1 M HEPES buffer, pH 7.5, which diffracted to 3.0 Å and belongs to the monoclinic space group P2₁. X-ray diffraction data were collected both at our in-house x-ray source, a Bruker M18XH6 MAC Science rotating anode interfaced to a Siemens X-1000 multiwire area detector and at the D03B protein crystallography beamline at the Laboratorio Nacional de Luz Síncrotron, Campinas, Brazil (11). Data reduction and processing were carried out with the programs MOSFLM, Scala, and Truncate from the CCP4 suite (12). Crystal packings were determined using the molecular replacement procedure as implemented in the AMoRe package (12), with the previously solved BLS structure as a search model. Crystallographic symmetry construction was carried out using the program O (13).

Structural Analysis
Total accessible surface area and buried surface areas of interaction (ASA) between monomers and pentamers in pentamer and decamer structures, respectively, were calculated with Surface Racer 1.2 program (14) using an implementation of the Lee and Richards (15) algorithm and a probe radius of 1.7 Å. Intermolecular polar and non-polar interactions were calculated with the Molmol 2k.2 (16) and Contacts of Structural Units (17) programs. Any pair of atoms is considered to be in contact if the distance between them is less than 4 Å.

	RESULTS

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
BLS Is a Stable Dimer of Pentamers in Solution—Previous studies (6, 9) have shown that BLS does not assemble as a 1-MDa capsid oligomer, having a retention time in SEC compatible with an apparent molecular mass of 90 kDa. This behavior suggested that the oligomeric structure of this protein in solution was a pentamer. However, the estimation of the molecular weight of a protein by its retention time on a SEC column is a method prone to artifacts. Additionally, the sequence divergence of BLS, compared with other pentameric LS, prompted us to re-analyze the quaternary structure of the protein by spectroscopic techniques such as static light scattering (SLS).

SLS experiments show that the protein has a molecular mass of 180 kDa in solution, corresponding to an assembly of two pentamers (decameric arrangement of the 18-kDa polypeptide chain). To characterize this new quaternary arrangement, we studied the thermodynamic stability of BLS, evaluating the unfolding of the protein induced by the common chemical denaturants (urea and GdnHCl) and pH.

Preincubation of BLS with increasing concentrations of urea shows that the enzyme remains as a stable dimer of pentamers, with no detectable change in its quaternary structure (180 kDa, determined by SLS, data not shown) as well as in its tertiary and secondary structures as followed by tryptophan fluorescence and CD (Fig. 1). The absence of structural changes, even in 8 M urea, indicates that the quaternary arrangement of BLS is very stable.

View larger version (12K): [in this window] [in a new window]   FIG. 1. Stability of BLS in presence of urea or GdnHCl monitored by FT and CD. A, percentage of fluorescence emission at 343 nm as a function of denaturant concentration. BLS samples (2.5 µM of monomers) were incubated in 50 mM sodium phosphate, pH 7.0, 1 mM DTT, with increasing concentration of urea (•) or GdnHCl (). Emission intensity of the sample incubated without GdnHCl was taken as 100%. The data represent the average of triplicate experiments. The estimated errors are below 10% of the average. B, far-UV CD spectra of native LS in 50 mM sodium phosphate, pH 7.0 (thin line), after incubation with urea 8 M (thick line), or after incubation with 6 M GdnHCl in the same buffer (dotted line).

Dissociation of BLS Dimer of Pentamers Is Tight and Precedes the Unfolding of the Pentamer—SLS analysis of the GdnHCl-induced unfolding of BLS shows a biphasic behavior (Fig. 2A). In the first step, observed between 1.5 and 2.2 M GdnHCl, the SLS signal intensity of the protein is reduced to half the value measured in the absence of denaturant. However, no changes in the far-UV CD spectra and tryptophan fluorescence of the protein are observed in this range (Figs. 1A and 2A). Thus, intrinsic tryptophan fluorescence is completely insensitive to the change in the quaternary structure of the protein, indicating that the dissociation does not modify significantly the environment of Trp-22. These results point to the existence of a dissociation phenomenon of the decameric structure of BLS into two pentameric subunits, with no further changes in tertiary and secondary structure. On the other hand, the second step observed between 2.4 and 3.5 M GdnHCl, shows a 5-fold decrease in the SLS signal of BLS concomitantly to the disappearance of its far-UV CD signal at 222 nm, and a significant decrease in the fluorescence intensity of its single tryptophan residue (Figs. 1A and 2A). These results are interpreted as an unfolding and loss of the tertiary and secondary structures of the protein coupled to the dissociation of its pentameric arrangement in five monomeric subunits (18 kDa). The overlapping of the changes observed in the second step by SLS, CD (Fig. 2A) and fluorescence (Fig. 1A) clearly supports our model. These results were further verified by SLS coupled to gel filtration chromatography (Fig. 2B), where it was possible to isolate a 90-kDa intermediate at 2 M GdnHCl. The fact that an intermediate of 90 kDa is stable enough to be detected by this methodology suggests that the decameric assembly is composed of two previously associated pentamers.

View larger version (15K): [in this window] [in a new window]   FIG. 2. Dissociation and unfolding of BLS monitored by circular dichroism and SLS. A, BLS samples (2.5 µM of monomers) were incubated in 50 mM sodium phosphate, pH 7.0, containing different amounts of GdnHCl. After 2 h of incubation at room temperature, the following parameters were measured: percentage of molar ellipticity at 222 nm () and molecular weight determined by SLS using a Sephadex G-25 column (). The values represent the average of at least three independent experiments. The estimated errors are below 10%. The CD data were adjusted to a two-state equation describing the unfolding from pentamer to monomers as described under "Experimental Procedures." B, elution profiles obtained for BLS in 50 mM sodium phosphate, pH 7.0, containing increasing [GdnHCl] as indicated on the graph. Samples were incubated for 2 h prior to injection into a pre-equilibrated Superdex-200 column. The arrows indicate the weight average molecular weight (w) of the peaks as determined by SLS in a flow-cell fashion.

View larger version (13K): [in this window] [in a new window]   FIG. 3. Dissociation and unfolding of BLS as a function of the pH. BLS samples (5 µM of monomers) were incubated in 50 mM acetate/citrate (pH 6.0–2.5) or sodium phosphate (pH 7.0–6.0). After 1-h incubation at room temperature, the following parameters were measured: , molecular weight determined by SLS using a Sephadex G-25 column; , percentage of molar ellipticity at 222 nm; or , percentage of ANS fluorescence intensity. ANS binding was monitored by 365-nm excitation and 470-nm emission.

Thermodynamic Stability of BLS Measured by Chemical Denaturation—To describe the thermodynamic stability of BLS, we studied the dissociation and unfolding steps taking advantage of the differential effect of GdnHCl at distinct concentration ranges. Both transitions (Steps 1 and 2) were shown to be highly cooperative and reversible. The dissociation step was characterized by SLS using GdnHCl up to 2.2 M, in a condition that does not disturb the tertiary and secondary structures of the pentamer. This assumption is supported by the facts that the circular dichroism spectrum is not modified (see Fig. 2A) and the intrinsic tryptophan fluorescence does not vary upon addition of GdnHCl (see Fig. 1A). The SLS determination of the equilibrium between the dimer of pentamers and the pentamer gives a G of 90 ± 20 kJ/mol decamer as estimated by the LEM method assuming a two-state transition (see "Experimental Procedures"). This value indicates that the protein remains as a decamer under physiological conditions (estimated K_D = 2.48 x 10^-16 M).

On the other hand, the transition from folded pentamer to unfolded monomers is a highly cooperative process that can be measured by GdnHCl denaturation at higher concentrations followed by tryptophan fluorescence (Fig. 1A), SLS, and circular dichroism (Fig. 2A). These signals show a sharp and overlapping change around 2.4–3.5 M GdnHCl. Thus, all three spectroscopic analyses rule out the existence of a populated intermediate during this transition. The dependence of [D]_50% with protein concentration (Table I) clearly supports the model of a two-state transition from a folded pentamer to unfolded monomers. Thermodynamic analysis of this equilibrium shows that the G is 330 ± 30 kJ/mol pentamer (Table I; see "Experimental Procedures" for details). In agreement with this analysis, GdnHCl denaturation of BLS previously incubated at pH 5.0 (as a dissociated pentamer, see Fig. 3), gives a G of 300 ± 30 kJ/mol pentamer, clearly indicating the accuracy of the determined thermodynamic parameter for the stability of the pentamer.

View larger version (16K): [in this window] [in a new window]   FIG. 4. Thermal denaturation of BLS monitored by CD. BLS samples (2.5 µM of monomers) were incubated for 2 h at room temperature in 50 mM sodium phosphate (dashed line), 50 mM sodium phosphate with 2 M GndHCl (solid line), and 50 mM acetate/citrate pH 4.5 (dotted line). Thermal denaturation was followed by CD and expressed as a percentage of molar ellipticity at 222 nm as a function of increasing temperature.

View larger version (63K): [in this window] [in a new window]   FIG. 5. Quaternary assembly of Brucella sp. LS. A, three different crystal forms of BLS show the same quaternary arrangement. BLS folds as a dimer of pentamers (each decamer is depicted in a different color) with spool-like shape. B, three-dimensional structure of the decameric BLS. Three monomers are shown in different colors to highlight the nature of this oligomeric intertwined structure. The ribbons and surface diagrams clearly show how the continuous helix 4 protrudes into the adjacent pentamer. C, the surface of BLS forming the pentamer-pentamer interface is shown. Histidine residues are colored in red, phenylalanines in yellow. The 5 C-terminal tips of helix 4 are highlighted in the periphery, whereas the internal circle of histidines is shown in the center, close to the pore that goes through the center of the pentamer.

View this table: [in this window] [in a new window]   TABLE II Analysis of the surface areas at the monomer-monomer and the pentamer-pentamer interfaces Polar and non-polar buried surface areas (ASA) of a monomer in monomer-monomer and pentamer-pentamer interactions are shown. All the calculations were made using a probe radius of 1.7Å. The percentage of the buried surface area of each monomer in a hypothetical situation being "free" in solution with respect to the total accessible surface area is represented in parentheses.

View larger version (39K): [in this window] [in a new window]   FIG. 6. Proposed mechanism of dissociation and unfolding of BLS. The dissociation of BLS renders intermediate folded pentamers, without any significant change in the secondary and tertiary structures. Dissociation is induced by 2 M [GdnHCl] at neutral pH; further increase of [GdnHCl] produces the concerted dissociation of the pentamer and unfolding of the 18-kDa monomer. Incubation at pH 5.0 without GdnHCl produces the same pentameric intermediate, with approximately the same thermodynamic stability as judged by GdnHCl denaturation. Thermodynamic estimates of dissociation and unfolding are shown.

	DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

In contrast, the pentamer presents an intertwined structure with each monomer interacting extensively with its adjacent monomers via multiple hydrophobic, hydrogen bond, and salt bridge interactions. As a consequence, dissociation of the pentamer and unfolding of the resulting monomers occurs as a concerted mechanism. Even though the macroscopic methods employed in this study support a two-state model, we cannot rule out the existence of intermediates. Because residues of neighboring monomers form the active site of the enzyme, there are no structural reasons for the existence of folded monomers.

The apparent transition temperature (T_m) of BLS is very high, typical of a protein from a thermophilic organism. Unexpectedly high T_m from other LS were previously described (5). Thermal unfolding of BLS shows an intermediate behavior between pentameric and icosahedric LS, as expected for its decameric order. The pentameric S. cerevisiae LS melting curve has a maximum at 74.1 °C, whereas icosahedric B. subtilis showed a sharp melting transition at 93.3 °C as determined by differential scanning calorimetry (DSC) (5). Circular dichroism experiments described in this work show that the melting point of BLS is 88 ± 2 °C, indicating a thermal stability closer to that of higher order LS. Preliminary differential scanning calorimetry experiments show a similar melting transition temperature (results not shown). Zhang et al. (5) postulated that the predominantly hydrophobic nature of BLS monomer-monomer interface as compared with other LS, would produce a higher thermal stability. In addition, previous dissociation of BLS to pentamers (see Figs. 2 and 3) yields a T_m of 70 ± 2 °C, close to the value of the pentameric S. cerevisiae LS. Thus, additional thermal stability of BLS can be attributed to the formation of the pentamer-pentamer interface. Our results and those of Zhang et al. show a clear relationship between quaternary order of pentameric assemblies and thermal stability. Moreover, the results shown here make BLS an excellent model to study the mechanisms of folding and thermodynamic stability of an oligomeric stable protein.

The new quaternary arrangement presented here raises the question about the biological implications of decameric LS. Moreover, a close inspection on the sequences of LS (8) suggests that the homologues from Rhodococcus erythropolis, Sinorhizobium meliloti, Mesorhizobium loti, Pseudomonas fluorescens, and possibly others are also decameric LS. A striking feature of the BLS structure is that the association of pentamers creates an internal space, delimitated by the external pores (8.5 Å of internal diameter) and two internal pores of around 23 Å of diameter (see Fig. 5C). These pores delimitate an empty space with the shape of a truncated cone and with a height of 60 Å. Although substrate channeling has to be ruled out because of the lack of an internal riboflavin synthase as in the case of icosahedric enzymes (31), the channels along the 5-fold axes (pores of 8.5 Å of diameter) could allow the passage of substrates but appear too narrow for the exit of lumazine (32). Thus, this structure could be acting as a reservoir of recently synthesized 6,7-dimethyl-8-ribityllumazine. The fact that BLS dissociates at acidic pHs, like those encountered at phagolysosomes, suggest a putative role of BLS as a transporter and reservoir of lumazine for riboflavin synthesis in the demanding conditions for surviving found inside eukaryotic cells (33). Experimental work is needed to demonstrate the validity of this hypothesis, but the low activity of this enzyme (9) and the existence of fluorescent products associated to recombinantly expressed purified BLS (resistant to urea dissociation) support this idea.

BLS folds as a highly stable dimer of pentamers and is a highly immunogenic protein (23, 34, 35). These characteristics resemble that of the B subunits of E. coli heat-labile enterotoxin (EtxB) and cholera toxin (CtxB). Both toxins assemble in vivo into exceptionally stable homopentameric complexes, which maintain their quaternary structure in a range of conditions that would normally be expected to cause protein denaturation (36). These remarkable stability properties, as well as the inherent immunogenicity of EtxB and CtxB pentamers, have prompted considerable interest in their use as vaccine delivery vehicles (36). Noteworthy, BLS is more stable to thermal denaturation than EtxB and CtxB toxins (T_m of 84 and 75 °C, respectively) (37, 38). Thus, BLS is a promising potential carrier for the polymeric delivery of antigens or epitopes. The presence of ten sites of linkage and the natural disordered conformation of its N termini (6) linked to its high stability indicate that BLS is a potential candidate for the development of subunit vaccines.

	FOOTNOTES

 
^* This work was supported in part by a Howard Hughes Medical Institute international grant (to F. A. G.), by a grant from the Agencia Nacional de Promoción Científica y Tecnológica, República Argentina, and by the Fundación Instituto Leloir. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Recipients of a fellowship from CONICET.

^|| Members of the research career of Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET).

^** To whom correspondence should be addressed. Tel: 54-11-4863-4012 (ext. 19); Fax: 54-11-4865-2246; E-mail: fgoldbaum{at}leloir.org.ar.

¹ The abbreviations used are: LS, lumazine synthase; BLS, Brucella sp. lumazine synthase; CD, circular dichroism; TF, tryptophan fluorescence; ANS, 1-anilino-8-naphthalene sulfonic acid; SLS, static light scattering; SEC, size exclusion chromatography column; LEM, lineal extrapolation method; GdnHCl, guanidine hydrochloride; _w, weight average molecular weight; DTT, dithiothreitol; ASA, accessible surface area.

	ACKNOWLEDGMENTS

 
We acknowledge the support of Fundación Instituto Leloir, Dr. Gonzalo Prat Gray for the critical reading of the manuscript, and D. Laplagne for help in the early steps of the work.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 

1. Ladenstein, R., Schneider, M., Huber, R., Bartunik, H. D., Wilson, K., Schott, K., and Bacher, A. (1988) J. Mol. Biol. 203, 1045-1070[CrossRef][Medline] [Order article via Infotrieve]
2. Gerhardt, S., Haase, I., Steinbacher, S., Kaiser, J. T., Cushman, M., Bacher, A., Huber, R., and Fischer, M. (2002) J. Mol. Biol. 318, 1317-1329[CrossRef][Medline] [Order article via Infotrieve]
3. Bacher, A. (1986) Methods Enzymol. 122, 192-199[Medline] [Order article via Infotrieve]
4. Ritsert, K., Huber, R., Turk, D., Ladenstein, R., Schmidt-Base, K., and Bacher, A. (1995) J. Mol. Biol. 253, 151-167[CrossRef][Medline] [Order article via Infotrieve]
5. Zhang, X., Meining, W., Fischer, M., Bacher, A., and Ladenstein, R. (2001) J. Mol. Biol. 306, 1099-1114[CrossRef][Medline] [Order article via Infotrieve]
6. Braden, B. C., Velikovsky, C. A., Cauerhff, A. A., Polikarpov, I., and Goldbaum, F. A. (2000) J. Mol. Biol. 297, 1031-1036[CrossRef][Medline] [Order article via Infotrieve]
7. Meining, W., Mortl, S., Fischer, M., Cushman, M., Bacher, A., and Ladenstein, R. (2000) J. Mol. Biol. 299, 181-197[CrossRef][Medline] [Order article via Infotrieve]
8. Fornasari, M. S., Laplagne, D. A., Frankel, N., Cauerhff, A. A., Goldbaum, F. A., and Echave, J. (2003) Mol. Biol. Evol. 10.1093/molbev/msg1244
9. Goldbaum, F. A., Velikovsky, C. A., Baldi, P. C., Mortl, S., Bacher, A., and Fossati, C. A. (1999) J. Med. Microbiol. 48, 833-839[Abstract/Free Full Text]
10. Greene, R. F., Jr., and Pace, C. N. (1974) J. Biol. Chem. 249, 5388-5393[Abstract/Free Full Text]
11. Polikarpov, I., Oliva, G., Castellano, E. E., Garratt, R. C., Arruda, P., Leite, A., and Craievich, A. (1998) Nucl. Instruments Methods Physics Res. A 405, 159-164
12. Navaza, J. A. C. (1994) Acta Crystallogr. Sect. A 50, 157-163[CrossRef]
13. Jones, T. A., Zou, J. Y., Cowan, S. W., and Kjeldgaard, M. (1991) Acta Crystallogr. Sect. A 47, 110-119
14. Tsodikov, O. V., Record, M. T., Jr., and Sergeev, Y. V. (2002) J. Comput. Chem. 23, 600-609[CrossRef][Medline] [Order article via Infotrieve]
15. Lee, B., and Richards, F. M. (1971) J. Mol. Biol. 55, 379-400[CrossRef][Medline] [Order article via Infotrieve]
16. Koradi, R., Billeter, M., and Wuthrich, K. (1996) J. Mol. Graph. 14, 51-55, 29-32[CrossRef][Medline] [Order article via Infotrieve]
17. Sobolev, V., Sorokine, A., Prilusky, J., Abola, E. E., and Edelman, M. (1999) Bioinformatics 15, 327-332[Abstract/Free Full Text]
18. Botelho, M. G., Gralle, M., Oliveira, C. L., Torriani, I., and Ferreira, S. T. (2003) J. Biol. Chem. 278, 34259-34267[Abstract/Free Full Text]
19. Kohn, W. D., Monera, O. D., Kay, C. M., and Hodges, R. S. (1995) J. Biol. Chem. 270, 25495-25506[Abstract/Free Full Text]
20. Semisotnov, G. V., Rodionova, N. A., Razgulyaev, O. I., Uversky, V. N., Gripas, A. F., and Gilmanshin, R. I. (1991) Biopolymers 31, 119-128[CrossRef][Medline] [Order article via Infotrieve]
21. Daniel, E., and Weber, G. (1966) Biochemistry 5, 1893-1900[CrossRef][Medline] [Order article via Infotrieve]
22. D'Alfonso, L., Collini, M., and Baldini, G. (1999) Biochim. Biophys. Acta 1432, 194-202[CrossRef][Medline] [Order article via Infotrieve]
23. Goldbaum, F. A., Polikarpov, I., Cauerhff, A. A., Velikovsky, C. A., Braden, B. C., and Poljak, R. J. (1998) J. Struct. Biol. 123, 175-178[CrossRef][Medline] [Order article via Infotrieve]
24. Jaenicke, R. (2000) J. Biotechnol. 79, 193-203[CrossRef][Medline] [Order article via Infotrieve]
25. Boudker, O., Todd, M. J., and Freire, E. (1997) J. Mol. Biol. 272, 770-779[CrossRef][Medline] [Order article via Infotrieve]
26. Guidry, J. J., Moczygemba, C. K., Steede, N. K., Landry, S. J., and Wittung-Stafshede, P. (2000) Protein Sci. 9, 2109-2117[Medline] [Order article via Infotrieve]
27. Reddy, G. B., Bharadwaj, S., and Surolia, A. (1999) Biochemistry 38, 4464-4470[CrossRef][Medline] [Order article via Infotrieve]
28. Dams, T., and Jaenicke, R. (1999) Biochemistry 38, 9169-9178[CrossRef][Medline] [Order article via Infotrieve]
29. Panse, V. G., Swaminathan, C. P., Aloor, J. J., Surolia, A., and Varadarajan, R. (2000) Biochemistry 39, 2362-2369[CrossRef][Medline] [Order article via Infotrieve]
30. Mok, Y. K., de Prat Gay, G., Butler, P. J., and Bycroft, M. (1996) Protein Sci. 5, 310-319[Medline] [Order article via Infotrieve]
31. Kis, K., Volk, R., and Bacher, A. (1995) Biochemistry 34, 2883-2892[CrossRef][Medline] [Order article via Infotrieve]
32. Ladenstein, R., Ritsert, K., Huber, R., Richter, G., and Bacher, A. (1994) Eur. J. Biochem. 223, 1007-1017[Medline] [Order article via Infotrieve]
33. Kohler, S., Michaux-Charachon, S., Porte, F., Ramuz, M., and Liautard, J. P. (2003) Trends Microbiol. 11, 215-219[Medline] [Order article via Infotrieve]
34. Goldbaum, F. A., Leoni, J., Wallach, J. C., and Fossati, C. A. (1993) J. Clin. Microbiol. 31, 2141-2145[Abstract/Free Full Text]
35. Velikovsky, C. A., Cassataro, J., Giambartolomei, G. H., Goldbaum, F. A., Estein, S., Bowden, R. A., Bruno, L., Fossati, C. A., and Spitz, M. (2002) Infect. Immun. 70, 2507-2511[Abstract/Free Full Text]
36. Ruddock, L. W., Coen, J. J., Cheesman, C., Freedman, R. B., and Hirst, T. R. (1996) J. Biol. Chem. 271, 19118-19123[Abstract/Free Full Text]
37. Ruddock, L. W., Webb, H. M., Ruston, S. P., Cheesman, C., Freedman, R. B., and Hirst, T. R. (1996) Biochemistry 35, 16069-16076[CrossRef][Medline] [Order article via Infotrieve]
38. Bhakuni, V., Xie, D., and Freire, E. (1991) Biochemistry 30, 5055-5060[CrossRef][Medline] [Order article via Infotrieve]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				E. Morgunova, S. Saller, I. Haase, M. Cushman, A. Bacher, M. Fischer, and R. Ladenstein Lumazine Synthase from Candida albicans as an Anti-fungal Target Enzyme: STRUCTURAL AND BIOCHEMICAL BASIS FOR DRUG DESIGN J. Biol. Chem., June 8, 2007; 282(23): 17231 - 17241. [Abstract] [Full Text] [PDF]

				V. Zylberman, S. Klinke, I. Haase, A. Bacher, M. Fischer, and F. A. Goldbaum Evolution of vitamin b2 biosynthesis: 6,7-dimethyl-8-ribityllumazine synthases of Brucella. J. Bacteriol., September 1, 2006; 188(17): 6135 - 6142. [Abstract] [Full Text] [PDF]

				P. M. Berguer, J. Mundinano, I. Piazzon, and F. A. Goldbaum A Polymeric Bacterial Protein Activates Dendritic Cells via TLR4 J. Immunol., February 15, 2006; 176(4): 2366 - 2372. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 279/9/8093    most recent M312035200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zylberman, V. Articles by Goldbaum, F. A. Search for Related Content PubMed PubMed Citation Articles by Zylberman, V. Articles by Goldbaum, F. A. Social Bookmarking                      What's this?